Abstract:Brown seaweeds rich in flavonoids and bioactive polysaccharides have shown potential effects of suppressing fat accumulation, oxidative stress, and inflammation in the liver. Refined seaweed compounds such as low‐molecular‐weight fucoidan and high‐stability fucoxanthin, have not been well studied regarding their biological function. Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases and is characterized by parameters of liver function and metabolic profiles. Therefore, the aim of this study was to determine the combined effect of fucoidan and fucoxanthin on NAFLD with respect to the biochemical parameters. Seventy patients with NAFLD confirmed by abdominal echography and FibroScan were screened. Patients with seafood allergy and those taking vitamin E, pioglitazone, or liraglutide were excluded. Forty‐two patients were randomly divided into a group receiving either fucoidan‐fucoxanthin mixture or placebo. Both groups were subjected to 12‐week follow‐up. The degree of fatty liver and liver fibrosis was detected using transient elastography (TE) with a controlled attenuation parameter (CAP) (FibroScan). The biochemistry of creatine, aspartate aminotransferase, alanine aminotransferase (ALT), and fasting blood sugar (FBS) was monitored every 4 weeks during the follow‐up period. Moreover, the metabolic profile, including cholesterol, triglyceride, adiponectin, leptin, uric acid, and insulin, as well as complete blood count/differential count and C‐reactive protein were measured at baseline, 4th, and 12th week of follow‐up. There were no significant differences in the baseline of age, gender, BMI (body mass index), and severity of fibrosis in both groups, but more severe steatosis was observed in the treatment group. Combined supplementation of fucoidan and fucoxanthin led to a significant reduction of serum ALT compared to the control (P < 0.05). No prominent change was detected in the CAP and adiponectin, which may imply that this short intervention is not enough to improve NAFLD in patients receiving fucoidan‐fucoxanthin binary mixture. In this pilot study, the seaweed derivative mixture can significantly reduce ALT, indicating that the combination of fucoidan and fucoxanthin might be a novel hepatoprotective supplement for NAFLD patients.

Association between consumption of edible seaweeds and newly diagnosed non‐alcohol fatty liver disease: The TCLSIH Cohort Study

The Sulfur Microbial Diet and Risk of Nonalcoholic Fatty Liver Disease: a Prospective Gene–diet Study from the UK Biobank

ASSA13-10-11 Nonalcoholic Fatty Liver Disease is Associated with Subclinical Atherosclerosis

Prospective study of seaweed consumption and thyroid cancer incidence in women: the Japan collaborative cohort study.

Association Between Serum Free Fatty Acid Levels and Nonalcoholic Fatty Liver Disease: a Cross-Sectional Study

Soy Food Intake Is Inversely Associated with Newly Diagnosed Nonalcoholic Fatty Liver Disease in the TCLSIH Cohort Study

Relationship between the consumption of wholegrain and nonalcoholic fatty liver disease: the TCLSIH Cohort Study

Low Docosahexaenoic Acid Content in Plasma Phospholipids is Associated with Increased Non-alcoholic Fatty Liver Disease in China

Dietary seaweed intake and depressive symptoms in Japanese adults: a prospective cohort study

Association of fish and meat consumption with non-alcoholic fatty liver disease: Guangzhou Biobank Cohort Study

Prevalence and Risk Factors for the Development of Nonalcoholic Fatty Liver Disease in a Nonobese Chinese Population: the Zhejiang Zhenhai Study.

Association of Non-alcoholic Fatty Liver Disease With Salt Intake and Dietary Diversity in Chinese Medical Examination Adults Aged 18–59 Years: A Cross-Sectional Study

Effects of Dietary Supplementation of Fish Oil Plus Vitamin D3 on Gut Microbiota and Fecal Metabolites, and Their Correlation with Nonalcoholic Fatty Liver Disease Risk Factors: a Randomized Controlled Trial

Serum Sialic Acid Level Is Significantly Associated with Nonalcoholic Fatty Liver Disease in a Nonobese Chinese Population: A Cross-Sectional Study

P21 Multisystem Health Consequences of Nonalcoholic Fatty Liver Disease: Phenome-Wide Mendelian Randomization and Disease-Trajectory Analyses

Consumption of Preserved Egg Is Associated with Modestly Increased Risk of Nonalcoholic Fatty Liver Disease in Chinese Adults

Low‐molecular‐weight fucoidan and high‐stability fucoxanthin decrease serum alanine transaminase in patients with nonalcoholic fatty liver disease—A double‐blind, randomized controlled trial

Negative association between antioxidant vitamin intake and non-alcoholic fatty liver disease in Chinese non-diabetic adults: mediation models involving superoxide dismutase

Prospective Study Of Perceived Dietary Salt Intake And The Risk Of Non-Alcoholic Fatty Liver Disease

Critique and Appraisal of a Study on the Attitudes Towards Organ Donor Advocacy Scale

Association between nutritional status indices and non-alcoholic fatty liver disease in older adults: insights from the National Health and Nutrition Examination Survey 2017–2018